Plate Reader and software. The A 2 platform can also be automated on a robotic liquid handling system for even higher throughput.
Protein MicroArray Platform can deliver more than a thousand results from a single microplate in less than five minutes.
The new Beckman Coulter platform is automation-friend ly and provides speed and flexibility. It overcomes many of the shortcomings of current microarray technology, including complicated sample handling and limited throughput. The highthroughput A 2 MicroArray System, part of Beckman Coulter's ProteomeLab™ family, is ideal for drug discovery applications and for research into diseases and their pathways.
The Plate Reader and software. The A 2 platform can also be automated on a robotic liquid handling system for even higher throughput.
The success of the technique lies in the A 2 MicroArray. Each well of the 96-well A 2 Plate has been prespotted with 13 different oligonucleotide sequences (ssDNA). Their complementary strands are provided as individually bottled reagents in the Universal Linker Kit. These reagents allow users to attach their antibody to the complementary oligo. Once synthesized, each oligonucleotide-antibody conjugate will bind to only one of the 13 oligonucleotide sequences attached to the bottom of the well, which will then capture only one of the 13 analytes of interest. The captured analytes are labeled with a second biotinylated antibody. Finally, detection is carried out with the use of a streptavidin-fluo r, visualized on the A 2 Plate Reader. The A 2 technique can be completely customized by the user, allowing for the addition of virtually any protein to the assay. One of the advantages of using an oligo is that the reactions are done off the surface of the microtiter plate and performed in solution, for increased sensitivity when detecting analytes within a cell culture, serum or plasma sample. Because the oligonucleotides, rather than the antibodies, are provided on the plate, the format offers a unique degree of flexibility. Researchers may develop their own assays by choosing from a range of antibodies, including their own custom antibodies. In many cases, customers have unique and proprietary protein targets and antibodies that are closely-held. This system will give these customers the flexibility and freedom to design and set up their own series of experiments. Future plans for this platform will enable other applications such as protein-protein, enzymatic, protein-DNA, post translational modification, DNA and RNA analysis.
To ensure the reliability of the assay, each of the 13 different analyte-specific oligonucleotide sequences and a 14 th reference spot have been printed on the plate in triplicate, for a total of 42 spots per well. The oligonucleotides are arranged in a 6 x 7 spot array at the bottom of each well with the reference spots positioned in three of the four corners.
The A 2 Plate Reader was specifically designed for optimum performance with the A 2 Universal Linker Kits. The A 2 Plate Reader and built-in software provide high-performance digital imaging and analysis. The reader features a cooled CCD camera capable of imaging a 96-well plate, one well at a time, in less than five minutes. The 12-bit CCD camera is enclosed to ensure a dark environment for the quantitative imaging of a variety of samples. Future applications of the A 2 Plate Reader will include complete systems integration with Beckman Coulter's Biomek ® platforms, for automation of the assay from start to finish. This will enable researchers to go from cells to results with minimal manual intervention.
The reader is a key element of any assay, and often represents a process bottleneck. With this entirely new approach of creating an array within a microtiter well, we can automate the sample preparation process as well as the detection and measurement of the analytes, with little or no manual intervention.
The flexibility and multiplexing capacity of the A 2 MicroArray products take ELISAs to a new level. The platform is ideal for researchers in assay development and validation, secondary drug screening and clinical research. It is particularly well-suited for applications working in a 96-well format where customization and flexibility are required. A 2 MicroArray technology will enable researchers to create panels of interest which could include assays such as cytokines, apoptosis, signal transduction, cell signaling and proteasomes.
Besides providing a system for multiplexed analysis, Beckman Coulter plans to offer additional plate formats with other spot densities. In the future, this system will enable researchers to study protein-protein interactions, protein-DNA reactions, post translational modifications, enzymatic reactions, protein-drug interactions, RNA and DNA. 
